表没食子儿茶素-3-没食子酸酯在人界面皮炎模型中显示抗炎作用
研究探讨表没食子儿茶素-3-没食子酸酯(EGCG)对人表皮界面皮炎(ID)体外模型的作用。结果显示,EGCG可降低CXCL10和MxA表达及CXCL10分泌,减轻细胞毒性并下调促炎细胞因子,提示其可能作为扁平苔藓等ID相关自身免疫性皮肤病的潜在局部治疗药物。
要点
- EGCG在ID体外模型中降低CXCL10和MxA的染色强度
- EGCG减少受刺激角质形成细胞的CXCL10分泌及细胞毒性
- EGCG下调多种维持ID的关键促炎细胞因子
核心结论
- EGCG在人界面皮炎体外模型中表现出抗炎作用,可抑制疾病维持相关的关键介质。
研究设计与样本
- 研究采用人表皮等效物和单层角质形成细胞的体外界面皮炎模型,并分析扁平苔藓患者皮损与健康皮肤进行对照。
主要发现
- CXCL10和MxA在扁平苔藓皮损中强表达,并在角质形成细胞受ID样刺激后诱导产生。
- EGCG降低表皮等效物中CXCL10和MxA的染色强度,并减少受刺激角质形成细胞的CXCL10分泌。
- EGCG减轻刺激的细胞毒性效应,并下调多种对ID维持关键的典型促炎细胞因子。
临床怎么用
- EGCG可能作为扁平苔藓及其他ID相关自身免疫性皮肤病的潜在局部治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epigallocatechin-3-gallate (EGCG) has been proven effective in treating viral warts. Since anticarcinogenic as well as anti-inflammatory properties are ascribed to the substance, its use has been evaluated in the context of different dermatoses. The effect of EGCG on interface dermatitis (ID), however, has not yet been explored. OBJECTIVES: In this study, we investigated the effect of EGCG on an epidermal human in vitro model of ID. METHODS: Via immunohistochemistry, lesional skin of lichen planus patients and healthy skin were analysed concerning the intensity of interferon-associated mediators, CXCL10 and MxA. Epidermal equivalents were stained analogously upon ID-like stimulation and EGCG treatment. Monolayer keratinocytes were treated likewise and supernatants were analysed via ELISA while cells were processed for vitality assay or transcriptomic analysis. RESULTS: CXCL10 and MxA are strongly expressed in lichen planus lesions and induced in keratinocytes upon ID-like stimulation. EGCG reduces CXCL10 and MxA staining intensity in epidermis equivalents and CXCL10 secretion by keratinocytes upon stimulation. It furthermore minimizes the cytotoxic effect of the stimulus and downregulates a magnitude of typical pro-inflammatory cytokines that are crucial for the perpetuation of ID. CONCLUSIONS: We provide evidence concerning anti-inflammatory effects of EGCG within a human in vitro model of ID. The capacity to suppress mediators that are centrally involved in disease perpetuation suggests EGCG as a potential topical therapeutic in lichen planus and other autoimmune skin diseases associated with ID.
引用
- Braegelmann C, Niebel D, Ferring-Schmitt S, et al. Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy. J Eur Acad Dermatol Venereol. 2021. PMID: 34585800. doi:10.1111/jdv.17710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。